IRADIMED CORPORATION (IRMD) Stock Analysis
Free AI-powered analysis and research for IRADIMED CORPORATION stock
Sector: Healthcare
Full IRMD report
IRADIMED CORPORATION (IRMD) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze IRMD Now βπ° Latest Update
IRadimed (IRMD) Stock Drops After Q3 Earnings Fail To Clear High Bar
Sun, November 1, 2026 at 2:06 PM UTC 2 min read
IRadimed (IRMD) saw its stock drop approximately 11% following its Q3 2026 earnings report, despite achieving record revenue of US$24.2 million and basic earnings per share of US$0.51. The decline is attributed to high investor expectations rather than a collapse in performance, as the company reported a 14% revenue increase year-over-year and improved net profit margins. Concerns remain regarding the impact of rising manufacturing costs on profitability amidst a new product rollout.